Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
13F holders, Q2 2024
Institutional positions in Kiora Pharmaceuticals Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −7 vs. Q1 2024
- Shares held
- 1.42M
- +183.2K (+14.8%) vs. Q1 2024Converted for a 1-for-9 split
- Total value
- $5.97M
- −$1.90M (−24.1%) vs. Q1 2024
- New holders
- 4
- 6 more added
- Sold out
- 11
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $2.91M |
| Q1 2026 | 18 | $654.7K |
| Q4 2025 | 19 | $1.39M |
| Q3 2025 | 17 | $1.71M |
| Q2 2025 | 16 | $2.68M |
| Q1 2025 | 18 | $3.87M |
| Q4 2024 | 16 | $4.16M |
| Q3 2024 | 19 | $5.38M |
| Q2 2024 | 17 | $5.97M |
| Q1 2024 | 24 | $7.87M |
| Q4 2023 | 15 | $159.5K |
| Q3 2023 | 14 | $91.9K |
| Q2 2023 | 18 | $425.2K |
| Q1 2023 | 14 | $283.6K |
| Q4 2022 | 11 | $518.8K |
| Q3 2022 | 9 | $209.0K |
| Q2 2022 | 14 | $391.0K |
| Q1 2022 | 16 | $517.0K |
| Q4 2021 | 13 | $1.22M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Kiora Pharmaceuticals Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 255,555 | $1.07M | 0.85% | 00.0% | UnchangedConverted for a 1-for-9 split |
| AIGH Capital Management LLC | 255,561 | $1.07M | 0.52% | 00.0% | UnchangedConverted for a 1-for-9 split |
| Nantahala Capital Management, LLC | 211,110 | $886.7K | 0.09% | 00.0% | UnchangedConverted for a 1-for-9 split |
| Stonepine Capital Management, LLC | 200,000 | $840.0K | 0.77% | +200,000 | New |
| Alyeska Investment Group, L.P. | 180,780 | $759.3K | 0.00% | −63,664−26.0% | ReducedConverted for a 1-for-9 split |
| ADAR1 Capital Management, LLC | 172,596 | $724.9K | 0.15% | +50,374+41.2% | AddedConverted for a 1-for-9 split |
| Velan Capital Investment Management LP | 122,223 | $513.3K | 0.29% | 00.0% | UnchangedConverted for a 1-for-9 split |
| Geode Capital Management, LLC | 13,771 | $57.8K | 0.00% | +9,636+233.1% | AddedConverted for a 1-for-9 split |
| UBS Group AG | 8,320 | $34.9K | 0.00% | +8,320 | New |
| BlackRock Inc. | 1,606 | $6.75K | 0.00% | 00.0% | UnchangedConverted for a 1-for-9 split |
| GWM Advisors LLC | 22 | $92 | 0.00% | −0−1.0% | ReducedConverted for a 1-for-9 split |
| Advisor Group Holdings, Inc. | 22 | $92 | 0.00% | +18+450.0% | AddedConverted for a 1-for-9 split |
| Bank of America Corp | 20 | $84 | 0.00% | +20 | New |
| US Bancorp | 8 | $34 | 0.00% | +1+7.5% | AddedConverted for a 1-for-9 split |
| Activest Wealth Management | 3 | $13 | 0.00% | +3 | New |
| Morgan Stanley | 1 | $4 | 0.00% | +0+12.5% | AddedConverted for a 1-for-9 split |
| JPMorgan Chase & Co | 1 | $4 | 0.00% | +1+125.0% | AddedConverted for a 1-for-9 split |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −8,889−100.0% | Sold outConverted for a 1-for-9 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −2,768−100.0% | Sold outConverted for a 1-for-9 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −2,730−100.0% | Sold outConverted for a 1-for-9 split |
| HRT Financial LP | 0 | $0 | 0.00% | −2,540−100.0% | Sold outConverted for a 1-for-9 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −1,851−100.0% | Sold outConverted for a 1-for-9 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −1,150−100.0% | Sold outConverted for a 1-for-9 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −1,134−100.0% | Sold outConverted for a 1-for-9 split |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −465−100.0% | Sold outConverted for a 1-for-9 split |
| Wells Fargo & Company | 0 | $0 | 0.00% | −7−100.0% | Sold outConverted for a 1-for-9 split |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-9 split |
| Albion Financial Group | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-9 split |